Clinical Trials
🇺🇸 FDA Page 30FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 349–360 of 380 articles
ReBEC Clinical Trial Registry Analysis: Brazil's 2020-2024 Trial Demographics & Therapeutics
Clinical Trial Cost Analysis 2024: FDA Insights on Phase 1-3 Expenses
Revolution Medicines Presents Updated Zoldonrasib Phase 1 Data for KRAS G12D Lung Cancer at AACR 2026
Whitehawk Therapeutics HWK-007 Shows Promise in AACR 2026 ADC Data Presentation
Nuance Pharma's Ohtuvayre Shows Improved Lung Function in Chinese COPD Patients - ENHANCE-CHINA Phase 3 Results Published
Lundbeck's VYEPTI Shows Improvement in Migraine-Related Cognitive Symptoms in Real-World INFUSE Study
Salubris Biotherapeutics JK06 Shows Promise in Phase 1/2 Cancer Trial at AACR 2024
Innate Pharma IPH5201 MATISSE Phase 2 Results Selected for AACR 2026 Clinical Trials Plenary Session
Accent Therapeutics ATX-295 Shows Promising Anti-Cancer Activity in Preclinical Studies at AACR 2026
Zai Lab's ZL-1503 Bispecific Antibody Shows Rapid Itch Relief in Atopic Disease Preclinical Studies
Zai Lab's ZL-1503 Bispecific Antibody Shows Promise for Rapid Itch Relief in Atopic Dermatitis Preclinical Study
Olema Oncology Presents Palazestrant and OP-3136 Preclinical Data at AACR 2026 for Breast Cancer Treatment